secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001193125-25-026192
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ovid Therapeutics receives Nasdaq deficiency notice for bid price below $1.00
-----------------------------------------------------------------------------

- Received Nasdaq notice on Feb 10, 2025, that average closing bid price was below $1.00 for 31 consecutive trading days.
- Company has 180 days, until Aug 11, 2025, to regain compliance by closing at $1.00 for 10 consecutive business days.
- No immediate impact on listing; common stock continues to trade on Nasdaq while options to cure are explored.
- If not cured by Aug 11, Ovid may seek a second 180-day period by transferring to Nasdaq Capital Market.
- Failure to cure could lead to delisting, with appeal rights to a Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000119312525026192/0001193125-25-026192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000119312525026192/d385884d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-026192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer